OID,Name,Description,Document,Pages,Title
RD.Table_14-3.01,Table 14-3.01,"Primary Endpoint Analysis: ADAS-Cog - Summary at Week 24 - LOCF
                            (Efficacy Population)
                        ",LF.CSR,2,Table 14-3.01
RD.Table_14-5.02,Table 14-5.02,"Incidence of Treatment Emergent Serious Adverse Events by
                            Treatment Group
                        ",LF.CSR,3,Table 14-5.02
